The Fas death factor
暂无分享,去创建一个
[2] P. Krammer,et al. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95) , 1995, Nature.
[3] S. Nagata,et al. TCR/CD3 coupling to Fas-based cytotoxicity , 1995, The Journal of experimental medicine.
[4] S. Nagata,et al. Selective apoptosis of CD4+CD8+ thymocytes by the anti-Fas antibody , 1995, The Journal of experimental medicine.
[5] John Calvin Reed,et al. Cloning and functional analysis of BAG-1: A novel Bcl-2-binding protein with anti-cell death activity , 1995, Cell.
[6] S. Nagata,et al. Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders. , 1995, The EMBO journal.
[7] C. Smith,et al. Fas ligand mediates activation-induced cell death in human T lymphocytes , 1995, The Journal of experimental medicine.
[8] E. Lacy,et al. Massive upregulation of the Fas ligand in lpr and gld mice: implications for Fas regulation and the graft-versus-host disease-like wasting syndrome , 1995, The Journal of experimental medicine.
[9] S. Nagata,et al. Fas and Fas ligand: lpr and gld mutations. , 1995, Immunology today.
[10] M. Boguski,et al. A novel RING finger protein interacts with the cytoplasmic domain of CD40. , 1994, The Journal of biological chemistry.
[11] I. Behrmann,et al. Structure of the human APO‐1 gene , 1994, European journal of immunology.
[12] S. Nagata,et al. Fas-mediated apoptosis in primary cultured mouse hepatocytes. , 1994, Experimental cell research.
[13] P. Kourilsky,et al. The expansion of a CD4+ T cell population bearing a distinctive β chain in MRL lpr/lpr mice suggests a role for the fas protein in peripheral T cell selection , 1994, European journal of immunology.
[14] Y. Laouar,et al. In vivo CD4+ lymph node T cells from lpr mice generate CD4-CD8-B220+TCR-beta low cells. , 1994, Journal of immunology.
[15] H. Gresham,et al. Spontaneous elaboration of transforming growth factor beta suppresses host defense against bacterial infection in autoimmune MRL/lpr mice , 1994, The Journal of experimental medicine.
[16] D. Newmeyer,et al. Cell-free apoptosis in Xenopus egg extracts: Inhibition by Bcl-2 and requirement for an organelle fraction enriched in mitochondria , 1994, Cell.
[17] Z. Oltvai,et al. Checkpoints of dueling dimers foil death wishes , 1994, Cell.
[18] N. Oyaizu,et al. Cross-linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-gamma and tumor necrosis factor-alpha secretion. , 1994, Blood.
[19] S. Nagata,et al. Increased Fas antigen expression in murine retrovirus‐induced immunodeficiency syndrome, MAIDS , 1994, European journal of immunology.
[20] K. Schulze-Osthoff,et al. Divergent signalling via APO‐1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. , 1994, The EMBO journal.
[21] F. Ramsdell,et al. Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death. , 1994, International immunology.
[22] P. Golstein,et al. T cell receptor‐induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A , 1994, European journal of immunology.
[23] J. Inazawa,et al. Human Fas ligand: gene structure, chromosomal location and species specificity. , 1994, International immunology.
[24] R. Testi,et al. Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase , 1994, The Journal of experimental medicine.
[25] K. Schulze-Osthoff,et al. Cell nucleus and DNA fragmentation are not required for apoptosis , 1994, The Journal of cell biology.
[26] M. Krönke,et al. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling , 1994, Cell.
[27] C. Walsh,et al. The role of the Fas lytic pathway in a perforin-less CTL hybridoma. , 1994, Journal of immunology.
[28] C. Goodnow,et al. Effects of the lpr mutation on elimination and inactivation of self-reactive B cells. , 1994, Journal of immunology.
[29] S. Nagata,et al. No requirement of reactive oxygen intermediates in Fas‐mediated apoptosis , 1994, FEBS letters.
[30] M. Seldin,et al. Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV‐1‐regulated protein gp34. , 1994, The EMBO journal.
[31] C. M. Eischen,et al. Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis. , 1994, Journal of immunology.
[32] D. Goeddel,et al. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor , 1994, Cell.
[33] J. Tschopp,et al. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways , 1994, Nature.
[34] I. N. Crisps,et al. Fatal interactions: fas-induced apoptosis of mature T cells , 1994 .
[35] K. Okumura,et al. Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. , 1994, Immunity.
[36] A. Abbas,et al. The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. , 1994, Immunity.
[37] I. Stamenkovic,et al. Fas and tumor necrosis factor receptor-mediated cell death: similarities and distinctions , 1994, The Journal of experimental medicine.
[38] H Hengartner,et al. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. , 1994, Science.
[39] Z. Darżynkiewicz,et al. CD4 engagement induces Fas antigen‐dependent apoptosis of T cells in vivo , 1994, European journal of immunology.
[40] P. Krammer,et al. Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells. , 1994, Journal of immunology.
[41] S. Yonehara,et al. Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[42] A. Benner,et al. High expression of APO-1 (CD95) on T lymphocytes from human immunodeficiency virus-1-infected children. , 1994, Blood.
[43] S. Ju,et al. Participation of target Fas protein in apoptosis pathway induced by CD4+ Th1 and CD8+ cytotoxic T cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[44] R. Kolesnick,et al. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling , 1994, Cell.
[45] Hans Hengartner,et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice , 1994, Nature.
[46] M R Alderson,et al. The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. , 1994, Immunity.
[47] C. Sidman,et al. A specific intercellular pathway of apoptotic cell death is defective in the mature peripheral T cells of autoimmune lpr and gld mice , 1994, European journal of immunology.
[48] B. Beutler,et al. Unraveling function in the TNF ligand and receptor families. , 1994, Science.
[49] F. Ramsdell,et al. gld/gld mice are unable to express a functional ligand for Fas , 1994, European journal of immunology.
[50] P. Golstein,et al. Fas‐based lymphocyte‐mediated cytotoxicity against syngeneic activated lymphocytes: A regulatory pathway? , 1994, European journal of immunology.
[51] M. Raff,et al. Programmed cell death and Bcl‐2 protection in the absence of a nucleus. , 1994, The EMBO journal.
[52] Matthew J. Brauer,et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. , 1994, Science.
[53] Terry Farrah,et al. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death , 1994, Cell.
[54] N. Jenkins,et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand , 1994, Cell.
[55] Timothy J. Ley,et al. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells , 1994, Cell.
[56] J. Mountz,et al. Correction of accelerated autoimmune disease by early replacement of the mutated lpr gene with the normal Fas apoptosis gene in the T cells of transgenic MRL-lpr/lpr mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[57] S. Nagata,et al. Purification and characterization of the Fas-ligand that induces apoptosis , 1994, The Journal of experimental medicine.
[58] D. Goeddel,et al. Fas antigen and p55 TNF receptor signal apoptosis through distinct pathways. , 1994, Journal of immunology.
[59] P. Erb,et al. Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity. , 1994, Journal of immunology.
[60] M. Seldin,et al. The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L- arginine , 1994, The Journal of experimental medicine.
[61] H. Boehmer. Positive selection of lymphocytes , 1994, Cell.
[62] G. J. V. Nossal,et al. Negative selection of lymphocytes , 1994, Cell.
[63] J. Sprent,et al. Expansion/deletion of mature T cells exposed to endogenous superantigens in vivo. , 1994, Journal of immunology.
[64] S. Grant,et al. Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[65] N. Hayashi,et al. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C , 1993, Hepatology.
[66] E. Lacy,et al. The onset of Fas expression parallels the acquisition of CD8 and CD4 in fetal and adult αβ thymocytes , 1994 .
[67] S. Nagata,et al. Fas and Fas ligand: a death factor and its receptor. , 1994, Advances in immunology.
[68] Takashi Suda,et al. Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor family , 1993, Cell.
[69] Junying Yuan,et al. Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3 , 1993, Cell.
[70] F. Chisari,et al. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis , 1993, The Journal of experimental medicine.
[71] B. Barres,et al. Programmed cell death and the control of cell survival: lessons from the nervous system. , 1993, Science.
[72] R. Eisenberg,et al. Selection of the T cell receptor repertoire in Lpr mice. , 1993, Journal of immunology.
[73] Y. Lazebnik,et al. Nuclear events of apoptosis in vitro in cell-free mitotic extracts: a model system for analysis of the active phase of apoptosis , 1993, The Journal of cell biology.
[74] L. Tartaglia,et al. A novel domain within the 55 kd TNF receptor signals cell death , 1993, Cell.
[75] J. Russell,et al. Autoimmune gld mutation uncouples suicide and cytokine/proliferation pathways in activated, mature T cells , 1993, European journal of immunology.
[76] S. Nagata,et al. Lethal effect of the anti-Fas antibody in mice , 1993, Nature.
[77] Shuji Takahashi,et al. Establishment of apoptosis‐inducing monoclonal antibody 2D1 and 2D1‐resistant variants of human T cell lines , 1993, European journal of immunology.
[78] J. Mountz,et al. Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene , 1993, The Journal of experimental medicine.
[79] K. Elkon,et al. The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon, ETn , 1993, The Journal of experimental medicine.
[80] S. Nagata,et al. Effect of bcl-2 on Fas antigen-mediated cell death. , 1993, Journal of immunology.
[81] T. Pohl,et al. Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. , 1993, Immunology today.
[82] P. Krammer,et al. Activation interferes with the APO-1 pathway in mature human T cells. , 1993, International immunology.
[83] S. Nagata,et al. A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. , 1993, The Journal of biological chemistry.
[84] C. Weaver,et al. Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[85] P. Marrack,et al. Profound deletion of mature T cells in vivo by chronic exposure to exogenous superantigen. , 1993, Journal of immunology.
[86] P. Möller,et al. Coregulation of the APO-1 antigen with intercellular adhesion molecule-1 (CD54) in tonsillar B cells and coordinate expression in follicular center B cells and in follicle center and mediastinal B-cell lymphomas. , 1993, Blood.
[87] T. Uede,et al. Transcriptional repression and differential splicing of Fas mRNA by early transposon (ETn) insertion in autoimmune lpr mice. , 1993, Biochemical and biophysical research communications.
[88] S. Nagata,et al. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[89] P. Golstein,et al. Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity , 1993, The Journal of experimental medicine.
[90] T. Miyawaki,et al. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. , 1992, Journal of immunology.
[91] M. Seldin,et al. Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci , 1992, The Journal of experimental medicine.
[92] P. Möller,et al. Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. , 1992, Journal of immunology.
[93] J. Inazawa,et al. Assignment of the human Fas antigen gene (Fas) to 10q24.1. , 1992, Genomics.
[94] J. Shiver,et al. Cytotoxicity with target DNA breakdown by rat basophilic leukemia cells expressing both cytolysin and granzyme A , 1992, Cell.
[95] P. Lichter,et al. The human APO-1 (APT) antigen maps to 10q23, a region that is syntenic with mouse chromosome 19. , 1992, Genomics.
[96] E. Jaffe,et al. A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease. , 1992, The Journal of clinical investigation.
[97] G. Lenoir,et al. Expression of the APO-1 antigen in Burkitt lymphoma cell lines correlates with a shift towards a lymphoblastoid phenotype. , 1992, Blood.
[98] M. Pawlita,et al. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. , 1992, The Journal of biological chemistry.
[99] M. Raff,et al. Social controls on cell survival and cell death , 1992, Nature.
[100] N. Copeland,et al. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis , 1992, Nature.
[101] L. Owen-Schaub,et al. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. , 1992, Cellular immunology.
[102] N. Copeland,et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. , 1992, Journal of immunology.
[103] H. von Boehmer,et al. Transgenic T cell receptor interactions in the lymphoproliferative and autoimmune syndromes of lpr and gld mutant mice , 1992, European journal of immunology.
[104] R. Aebersold,et al. A natural killer cell granule protein that induces DNA fragmentation and apoptosis , 1992, The Journal of experimental medicine.
[105] K. Rajewsky. Early and late B-cell development in the mouse. , 1992 .
[106] V. Fadok,et al. Apoptosis and programmed cell death in immunity. , 1992, Annual review of immunology.
[107] L. David Tomei,et al. Apoptosis: The Molecular Basis of Cell Death , 1991 .
[108] A. Sher,et al. Diversity of Cytokine Synthesis and Function of Mouse CD4+ T Cells , 1991, Immunological reviews.
[109] H. Macdonald,et al. Clonal expansion precedes anergy and death of Vβ8+ peripheral T cells responding to staphylococcal enterotoxin B in vivo , 1991, European journal of immunology.
[110] Atsushi Hase,et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis , 1991, Cell.
[111] B. Rocha,et al. Peripheral selection of the T cell repertoire. , 1991, Science.
[112] R. Eisenberg,et al. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. , 1991, Annual review of immunology.
[113] J. Sprent,et al. Extrathymic tolerance of mature T cells: Clonal elimination as a consequence of immunity , 1990, Cell.
[114] N. Yamamoto,et al. Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[115] J. D. Marshall,et al. Differences defined by bone marrow transplantation suggest that lpr and gld are mutations of genes encoding an interacting pair of molecules. , 1990, The Journal of experimental medicine.
[116] Ishiura Shoichi,et al. Calcium is essential for both the membrane binding and lytic activity of pore-forming protein (perforin) from cytotoxic T-lymphocyte☆ , 1990 .
[117] M. Egerton,et al. Kinetics of mature T-cell development in the thymus. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[118] T. Waldmann,et al. Monoclonal-antibody-mediated apoptosis in adult T-cell leukaemia , 1990, The Lancet.
[119] T. Katagiri,et al. A new allele of the lpr locus, lprcg, that complements the gld gene in induction of lymphadenopathy in the mouse , 1990, The Journal of experimental medicine.
[120] P. Möller,et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis. , 1989, Science.
[121] S. Yonehara,et al. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor , 1989, The Journal of experimental medicine.
[122] S. Jonjić,et al. Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes , 1989, The Journal of experimental medicine.
[123] D. Purves. Body and Brain: A Trophic Theory of Neural Connections , 1988 .
[124] J. D. Young,et al. A calcium- and perforin-independent pathway of killing mediated by murine cytolytic lymphocytes , 1987, The Journal of experimental medicine.
[125] M. Sitkovsky,et al. Exocytosis of cytolytic granules may not be required for target cell lysis by cytotoxic T-lymphocytes , 1987, Nature.
[126] J. D. Young,et al. Dissociation of membrane binding and lytic activities of the lymphocyte pore-forming protein (perforin) , 1987, The Journal of experimental medicine.
[127] H. Ostergaard,et al. Cytotoxic T lymphocyte mediated lysis without release of serine esterase , 1987, Nature.
[128] J. D. Young,et al. Isolation and biochemical and functional characterization of perforin 1 from cytolytic T-cell granules. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[129] G. Berke,et al. T-Lymphocyte-mediated cytolysis as an excitatory process of the target. I. Evidence that the target cell may be the site of Ca2+ action. , 1985, Cellular immunology.
[130] R. Balderas,et al. Association of lpr gene with graft-vs.-host disease-like syndrome , 1985, The Journal of experimental medicine.
[131] P. Henkart. Mechanism of lymphocyte-mediated cytotoxicity. , 1985, Annual review of immunology.
[132] E. Podack. The molecular mechanism of lymphocyte-mediated tumor cell lysis. , 1985, Immunology today.
[133] V. Kelley,et al. Induction of various autoantibodies by mutant gene lpr in several strains of mice. , 1984, Journal of immunology.
[134] E. Eicher,et al. A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H/HeJ mice , 1984, The Journal of experimental medicine.
[135] I. Weissman,et al. Thymus cell migration: Quantitative aspects of cellular traffic from the thymus to the periphery in mice , 1980, European journal of immunology.
[136] I. Maclennan,et al. Limited specific T-cell mediated cytolysis in the absence of extracellular Ca2+. , 1980, Immunology.
[137] A. Theofilopoulos,et al. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains , 1978, The Journal of experimental medicine.